Cargando…
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson's Disease Models
Few pharmaceutical agents for slowing Parkinson's disease (PD) progression existed, especially for perimenopause females. The current general medications are mostly hormone replacement therapy and may have some side effects. Therefore, there is an urgent need for a novel treatment for PD. This...
Autores principales: | Lee, Yung-Shih, Feng, Chien-Wei, Peng, Mei-Yu, Chan, Te-Fu, Chen, Yu-Chieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556090/ https://www.ncbi.nlm.nih.gov/pubmed/34721835 http://dx.doi.org/10.1155/2021/3064892 |
Ejemplares similares
-
Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo
por: Lo, Yi-Ching, et al.
Publicado: (2012) -
Neuroprotective effects of novel compound Tozan on cognition, neurogenesis and apoptosis in diabetes
por: Tang, Su-Su, et al.
Publicado: (2021) -
Differential Angiogenic Properties of Lithium Chloride In Vitro and In Vivo
por: Zeilbeck, Ludwig F., et al.
Publicado: (2014) -
Lithium Chloride Exerts Anti-Inflammatory and Neuroprotective Effects by Inhibiting Microglial Activation in LPS-Induced Retinal Injury
por: Wu, Nandan, et al.
Publicado: (2023) -
Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson's Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo
por: Feng, Chien-Wei, et al.
Publicado: (2020)